Is the Type of Cardiovascular Response During Tilt Table Testing Useful for the Choice of the Treatment? The New VASIS Classification
Worldwide experience of more than 10 years of tilt testing has shown that, while it has dramatically reduced the number of patients whose syncope cannot be explained, the population of patients who show a positive response to the test is greatly heterogeneous, raising the possibility that different syndromes can be diagnosed by tilt testing. Many drugs as well as cardiac pacing have been proposed for patients with tilt-induced syncope; however, a consensus on management has not been achieved due to the unsatisfactory results of trials of therapy which have been undertaken. The classification of the Vasovagal Syncope International Study (VASIS) was developed in 1992 in order to facilitate the understanding of the different types of vasovagal reactions that were observed during tilt-induced syncope . This has been recently extended to tilt testing with pharmacological challenge [2, 3]. Like the other current classifications of the positive responses to tilt testing, the VASIS classification is based on the different behaviour of the blood pressure and heart rate observed when the vasovagal reaction and symptoms occur. To date, the cardiovascular patterns preceding the development of the vasovagal reaction have received little study. We believe that the pattern of blood pressure response to tilt may provide more strict diagnostic information and that a more detailed although still arbitrary classification may form the basis of a number of future drug and pacemaker trials and may help us toward a better understanding of the different mechanisms of tilt-induced syncope. We, therefore, propose that the following classification should be used as a complementary classification in addition to the VASIS classification. Moreover, we have tried to correlate this classification with some simple clinical variables.
KeywordsChronic Fatigue Syndrome Carotid Sinus Orthostatic Intolerance Vasovagal Syncope Tilt Table Test
Unable to display preview. Download preview PDF.
- 1.Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P (1992) Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 2:180–183Google Scholar
- 2.Del Rosso A, Bartoli P, Bartoletti A, Brandinelli-Geri A, Bonechi F, Maioli M, Mazza F, Michelucci A, Russo L, Salvetti E, Sansoni M, Zipoli A, Fierro A, Ieri A (1998) Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am Heart J 135:564–570PubMedCrossRefGoogle Scholar
- 3.Kurbaan AS, Fran’zen AC, Williams T, Wasan BS, Kaddoura S, Sutton R (1998) Vasovagal collapse patterns after the use of glyceryl trinitrate during tilt testing. PACE 21:794 (abstr)Google Scholar
- 8.Petersen MEV, Williams TR, Sutton R (1995) A comparison of non-invasive continuous finger blood pressure measurements (Finapres) with intra-arterial pressure during prolonged head-up tilt. Eur Heart J 16:1647–1654Google Scholar
- 9.Grubb B, Samoil D (1996) Neurocardiogenic syncope. In: Kenny RA (ed) Syncope in the older patient. Chapman & Hall, pp 91–106Google Scholar
- 11.Betkoski A, Patei C, Halperin A, Jaeger F, Goren H, Fouad-Tarazi F (1995) Reporting on the results of tilt patterns of response offer more information than changes at end-point. Circulation 92:I–203 (abstr)Google Scholar
- 25.Di Gerolamo E, Di Iorio C, Sabatini P, Leonzio I, Barsotti A (1998) Effects of different treatments versus no treatment on neurocardiogenic syncope. Cardiologia 43:833–837Google Scholar
- 26.Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, Moya A (1999) Effect of etilefrine in preventing syncopal recurrence in patients with tilt-induced vasovagal syncope. A double-blind, randomized, placebo-controlled trial. Circulation (in press)Google Scholar
- 28.Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giani P, Moya A (1999) Dualchamber pacing is efficacious in treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicentre randomized study (in press)Google Scholar
- 29.Ector H, Reybrouck T, Heidbuchel H, Van de Werf F (1998) Tilt training: a new treatment for neurocardiogenic syncope. Arch Mal Coeur Vaisseaux 91:32 (abstr)Google Scholar